U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H18N2O2
Molecular Weight 354.4012
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ISOFEZOLAC

SMILES

OC(=O)CC1=C(C(=NN1C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4

InChI

InChIKey=LZRDDINFIHUVCX-UHFFFAOYSA-N
InChI=1S/C23H18N2O2/c26-21(27)16-20-22(17-10-4-1-5-11-17)23(18-12-6-2-7-13-18)24-25(20)19-14-8-3-9-15-19/h1-15H,16H2,(H,26,27)

HIDE SMILES / InChI

Molecular Formula C23H18N2O2
Molecular Weight 354.4012
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

ISOFEZOLAC is a non-steroid anti-inflammatory drug, prostaglandin synthetase inhibitor. It is indicated for use in various forms of rheumatoid arthritis and osteoarthritis.

Approval Year

PubMed

PubMed

TitleDatePubMed
Effect of probenecid on isofezolac kinetics.
1985
The effect of antacid and aspirin on the bioavailability of isofezolac in man.
1984-09
Study of two new non-steroid anti-inflammatory drugs having a pyrazole structure (LM 22070 and LM 22102).
1979-04
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:33:23 GMT 2025
Edited
by admin
on Mon Mar 31 18:33:23 GMT 2025
Record UNII
7K6U6T1360
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ISOFEZOLAC
INN   MI   WHO-DD  
INN  
Official Name English
ISOFEZOLAC [MI]
Preferred Name English
isofezolac [INN]
Common Name English
1,3,4-TRIPHENYLPYRAZOLE-5-ACETIC ACID
Systematic Name English
Isofezolac [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C257
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
Code System Code Type Description
SMS_ID
100000082829
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
FDA UNII
7K6U6T1360
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
MERCK INDEX
m250
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY Merck Index
INN
4438
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
EVMPD
SUB08317MIG
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
NCI_THESAURUS
C65977
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
ChEMBL
CHEMBL2104795
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
CAS
50270-33-2
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
DRUG CENTRAL
1492
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
EPA CompTox
DTXSID40198273
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
PUBCHEM
68677
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
MESH
C020696
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
ECHA (EC/EINECS)
256-512-1
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY